Clinical Trials Directory

Trials / Completed

CompletedNCT04289311

SMYLS: A Self-management Program for Youth Living With Sickle Cell Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Medical University of South Carolina · Academic / Other
Sex
All
Age
11 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to find out whether a web-based intervention using a mobile device is helpful for teens learning to care for and manage symptoms of sickle cell disease. The intervention lasts 12 weeks with a 3-month follow up period, and uses a smartphone or a tablet.

Detailed description

The purpose of the proposed study is to test the feasibility of SMYLS, an mHealth intervention designed to facilitate self-management behaviors in children and adolescents with sickle cell disease (SCD). Specifically, the investigators propose to test the feasibility of the intervention for improving transition from parent-managed to adolescent self-managed care. In addition, the investigators will evaluate the communication that takes place via the intervention between adolescents, their parents/caregivers, and healthcare providers. The investigators will work with the MUSC Pediatric Sickle Cell Clinic to identify and recruit 5 healthcare providers of children with SCD and 30 dyads of adolescents ages 11 - 17 SCD and their parent/caregiver (n = 60).

Conditions

Interventions

TypeNameDescription
BEHAVIORALVoice Crisis Alert V2An mHealth intervention (app) with multiple components for self-management behavior development. Components include: electronic educational information, symptom monitoring and tracking, communication with a provider, health history entry and storage (including medication adherence).

Timeline

Start date
2020-07-13
Primary completion
2021-05-11
Completion
2021-12-17
First posted
2020-02-28
Last updated
2024-08-16
Results posted
2024-08-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04289311. Inclusion in this directory is not an endorsement.